News | August 02, 2007

OncoLogics Inc. Signs Deal for Developing PBRT System

August 3, 2007 - OncoLogics Inc., a comprehensive radiosurgical and radiation therapy clinic in southwest Louisiana, announced that it has entered into an agreement to purchase a Clinatron-250 proton beam radiation therapy (PBRT) system, still under development, from Still River Systems, reportedly becoming the only center in Louisiana to commit to this technology.

Te Clinatron 250 PBRT System is said to be a practical, cost-efficient, single-room PBRT system scaled for use at most cancer centers. The heart of the Clinatron 250 System will be a compact, superconducting high field magnet which directs a proton beam toward a precisely defined isocenter.

Included in the Clinatron 250 PBRT System will be a cyclotron, the proton beam delivery system, a treatment couch with pendant control, a radiographic patient positioning system, proton beam treatment planning, and a link to a treatment record and verify system.

Currently, five U.S. health care facilities have large-scale proton beam Radiation therapy systems which weigh more than 440,000 pounds, require almost 100,000 square feet of space and carry a price tag upward of $150 million for the equipment and building. A group of physicists and scientists from MIT and other academic proton research facilities have spent years developing a smaller, more economical cyclotron that can produce and deliver protons for Radiation therapy. To date, nine centers have committed to purchasing this new technology.

For more information: www.OncoLogics.net and www.stillriversystems.com

Related Content

University Medical Center Groningen Performs First Automatic Log-based Proton Therapy Patient QA
News | Proton Therapy | June 14, 2019
IBA announced the physics team of University Medical Center Groningen (UMCG) in the Netherlands has developed and...
IBA Dosimetry Launches myQA iON
News | Quality Assurance (QA) | June 07, 2019
IBA (Ion Beam Applications S.A.) announced the launch of myQA iON at the 2019 Particle Therapy Co-Operative Group (...
Proton Therapy Lowers Risk of Side Effects Compared to Conventional Radiation
News | Proton Therapy | May 23, 2019
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of...
IBA Partnering to Develop Advanced Digital Proton Therapy Technologies in Belgium
News | Proton Therapy | May 10, 2019
IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain...
Netherlands Proton Therapy Center Delivers First Clinical Flash Irradiation
News | Proton Therapy | May 02, 2019
IBA (Ion Beam Applications SA) recently announced the first Flash irradiation in an IBA proton therapy gantry treatment...
Pencil Beam Scanning Better Protects Children With Brain Tumors
News | Proton Therapy | May 01, 2019
A comparison of three types of radiotherapy for children's brain tumors suggests a type of proton therapy called pencil...
California Protons Cancer Therapy Center Begins Breast Cancer Study Enrollment
News | Proton Therapy | April 25, 2019
California Protons Cancer Therapy Center announced two major efforts representing significant steps forward in breast...
Varian Discloses First Preclinical Results of Flash Therapy in Cancer Treatment
News | Proton Therapy | April 09, 2019
Varian, in partnership with the University of Maryland School of Medicine’s Department of Radiation Oncology and the...
ZON-PTC in Clinical Use With RayStation 8B and Hyperscan
News | Treatment Planning | March 19, 2019
Zuid-Oost Nederland Protonen Therapie Centrum (ZON-PTC), Maastricht, Netherlands, recently treated its first patient...
What to Expect from the Proton Therapy Market in 2019-2020
News | Proton Therapy | March 13, 2019
The number of new particle therapy rooms ordered worldwide dropped by almost 20 percent in 2018, according to a new...